Modulation of cellular calcium by sigma-2 receptors: Release from intracellular stores in human SK-N-SH neuroblastoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 900-911

  Vilner, Bertold J ^a   Bowen, Wayne D ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER RECEPTOR; SIGMA OPIATE RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENANTIOMER; HUMAN; HUMAN CELL; LIGAND BINDING; NEUROBLASTOMA; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

CALCIUM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; MORPHINE; NEUROBLASTOMA; RECEPTORS, SIGMA; TUMOR CELLS, CULTURED;

EID: 0034053453     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Basile AS, Paul IA and de Costa B (1992) Differential effects of cytochrome P-450 induction on ligand binding to sigma receptors. Eur J Pharmacol 227:95-98.
2. Berridge MJ, Bootman MD and Lipp P (1998) Calcium: A life and death signal. Nature (Lond) 395:645-648.
3. Bertha CM, Vilner BJ, Mattson MV, Bowen WD, Becketts K, Xu H, Rothman RB, Flippen-Anderson JL and Rice KC (1995) (E)-8 Benzylidene derivatives of 2-methyl-5-(3-hydroxyphenyl)morphans: Highly selective ligands for the sigma-2 receptor subtype. J Med Chem 38:4776-4785.
4. Bowen WD, Bertha CM, Vilner BJ and Rice KC (1995a) CB-64D and CB-184: Ligands with high sigma-2 receptor affinity and subtype selectivity. Eur J Pharmacol 278:257-260.
5. Bowen WD, Coop A and Vilner BJ (1999) Sigma-2 receptors that modulate calcium and induce cytotoxicity are localized intracellularly. Soc Neurosci Abstr 25:1708.
6. 3H](+)-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol Neuropharmacol 3:117-126.
7. Bowen WD, Tolentino PJ, Kirschner BN, Varghese P, de Costa BR and Rice KC (1993b) Sigma receptors and signal transduction: Negative modulation of signalling through phosphoinositide-linked receptor systems, in Sigma, PCP, and NMDA Receptors - National Institute on Drug Abuse Research Monograph 133 (DeSouza EB, Clouet DH and London ED eds) pp 69-93, US Government Printing Office, Washington, DC.
8. Bowen WD and Vilner BJ (1994) Sigma receptor-mediated morphological and cytotoxic effects on primary cultures of rat central and peripheral nervous system. Soc Neurosci Abstr 20:747.
9. Bowen WD, Vilner BJ, Bandarage UK and Kuehne ME (1996) Ibogaine and ibogamine modulate intracellular calcium levels via interaction with sigma-2 receptors. Soc Neurosci Abstr 22:2006.
10. 2 receptor-selective ligands with moderate affinity. Eur J Pharmacol 279:R1-R3.
11. Bowen WD, Walker JM, de Costa BR, Wu R, Tolentino PJ, Finn D, Rothman RB and Rice KC (1992) Characterization of the enantiomers of ds-N-[2-l3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)cyclohexylamine (BD737 and BD738): Novel compounds with high affinity, selectivity, and biological efficacy at sigma receptors. J Pharmacol Exp Ther 262:32-40.
12. 1 in colon and mammary adenocarcinoma cells. Biochem Biophys Res Commun 219:219-226.
13. Clapham DE (1995) Calcium signaling. Cell 80:259-268.
14. Couture S and Debonnel G (1998) Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma-2 ligands. Synapse 29:62-71.
15. Cutts JM, de Costa BR and Bowen WD (1993) Sigma ligands have reduced ability to inhibit the muscarinic phosphoinositide response in cells deficient in sigma-1 receptors, in Problems of Drug Dependence, 1992: Proceeding of the 54th Annual Scientific Meeting, National Institute on Drug Abuse Research Monograph 132 (Harris LS ed) p 403, US Government Printing Office, Washington, DC.
16. de Costa BR, Dominguez C, He XS, Williams W, Radesca L and Bowen W (1992a) Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl ethylenediamines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine and tetrahydroisoquinoline classes. J Med Chem 35:4334-4343.
17. de Costa BR, Radesca L, Di Paolo L and Bowen WD (1992b) Synthesis, characterization and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: Structural requirements and binding affinity at the sigma receptor. J Med Chem 35:38-47.
18. +- influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 269:1300-1309.
19. Fisher SK and Snider RM (1987) Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas. Mol Pharmacol 32:81-90.
20. 1-binding site. Proc Natl Acad Sci USA 93:8072-8077.
21. Hellewell SB and Bowen WD (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that in guinea pig brain. Brain Res 527:244-253.
22. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W and Bowen WD (1994) Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: Characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 268:9-18.
23. Itzhak Y ed (1994) The Sigma Receptors: Neuroscience Perspectives Series. Academic Press, London, UK.
24. Itzhak Y, Stein I, Zhang SH, Kassim CO and Cristante D (1991) Binding of sigma-ligands to C57BL/6 mouse brain membranes: Effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. J Pharmacol Exp Ther 257:141-148.
25. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD and de Costa BR (1995) Characterization of two novel sigma ligands: Antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280:301-310.
26. 3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions. Eur J Pharmacol 188:211-218.
27. McConkey DJ and Orrenius S (1996) The role of calcium in the regulation of apoptosis. J Leuk Biol 59:775-783.
28. Novakova M, Ela C, Bowen WD, Hasin Y and Eilam Y (1998) Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 353:315-327.
29. Pozzan T, Rizzuto R, Volpe P and Meldolesi J (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 74:595-636.
30. Putney JWJ (1990) Capacitative calcium entry revisited. Cell Calcium 11:611-624.
31. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW and Taylor DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85-86.
32. Ross RA, Spengler BA and Biedler JL (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-747.
33. 2+ stores: Activation and function. Trends Neurosci 18:299-306.
34. 2+ mobilization and sigma-1 receptor antisense studies. Soc Neurosci Abstr 24:2055.
35. Vilner BJ, Bandarage UK, Kuehne ME, Bertha CM and Bowen WD (1998) The neurotoxic effect of iboga alkaloids may be mediated by sigma-2 receptors, in Problems of Drug Dependence, 1997: Proceedings of the 59th Annual Scientific Meeting, National Institute on Drug Abuse Research Monograph 178 (Harris LS ed) p 235, US Government Printing Office, Washington, DC.
36. Vilner BJ and Bowen WD (1995) Dual modulation of cellular calcium by sigma receptor ligands: Release from intracellular stores and blockade of voltage-dependent influx. Soc Neurosci Abstr 21:1608.
37. Vilner BJ and Bowen WD (1997) Sigma-2 receptor agonists induce apoptosis in rat cerebellar granule cells and human SK-N-SH neuroblastoma cells. Soc Neurosci Abstr 23:2319.
38. Vilner BJ, de Costa BR and Bowen WD (1995a) Cytotoxic effects of sigma ligands: Sigma receptor-mediated alterations in cellular morphology and viability. J Neurosci 15:117-134.
39. Vilner BJ, John CS and Bowen WD (1995b) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 55:408-413.
40. Walker JM, Bowen WD, Walker FO, Matsumoto RR, de Costa BR and Rice KC (1990) Sigma receptors: Biology and function. Pharmacol Rev 42:355-402.